Ritonavir pharmacokinetics alone and in combination with saquinavir in HIV-infected patients. 1998

C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D019258 Saquinavir An HIV protease inhibitor which acts as an analog of an HIV protease cleavage site. It is a highly specific inhibitor of HIV-1 and HIV-2 proteases, and also inhibits CYTOCHROME P-450 CYP3A. Invirase,Ro 31-8959,Saquinavir Mesylate,Saquinavir Monomethanesulfonate,Saquinivir,Monomethanesulfonate, Saquinavir,Ro 31 8959,Ro 318959
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D019438 Ritonavir An HIV protease inhibitor that works by interfering with the reproductive cycle of HIV. It also inhibits CYTOCHROME P-450 CYP3A. ABT 538,ABT-538,Norvir,ABT538

Related Publications

C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
September 2005, British journal of clinical pharmacology,
C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
December 2008, The Journal of antimicrobial chemotherapy,
C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
June 2008, Clinical pharmacology and therapeutics,
C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
November 2004, Journal of acquired immune deficiency syndromes (1999),
C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
October 2007, Clinical pharmacology and therapeutics,
C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
October 2005, British journal of clinical pharmacology,
C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
December 2001, Antimicrobial agents and chemotherapy,
C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
June 2001, British journal of clinical pharmacology,
C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
April 2003, Journal of acquired immune deficiency syndromes (1999),
C Merry, and M G Barry, and F Mulcahy, and J F Tjia, and K L Halifax, and J Heavey, and C Kelly, and D J Back
August 2005, European journal of clinical pharmacology,
Copied contents to your clipboard!